This inventor holds 14 USPTO granted patents and 1 published patent application, primarily in Neurodegenerative Research. Top assignees: Elan Pharmaceuticals, Inc., Elan Pharma International Limited, Janssen Sciences Ireland Uc. Active years: 2003-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
11 out of 202 
2 out of 80 
1 out of 111 
Years Active: 2003-2015
Areas of Expertise:
Title: Guriqbal Basi: Innovator in Antibody Research
Introduction
Guriqbal Basi is a prominent inventor based in Palo Alto, California, known for his significant contributions to the field of antibody research. With a total of 14 patents to his name, Basi has made remarkable strides in developing innovative solutions for various medical challenges.
Latest Patents
Among his latest patents, Basi has developed hybrid amyloid-beta antibodies. This invention provides crystals that include amino acids 1-7 of SEQ ID NO:1 and a Fab fragment of 12A11, 12B4, 10D5, or 3D6. Additionally, it encompasses amino acids 1-40 of SEQ ID NO:1 and a Fab fragment of 12A11 or 3D6. The invention also outlines methods for preparing these crystals. Furthermore, Basi has introduced a computer-implemented method for analyzing the binding of a candidate antibody fragment to a peptide that includes an epitope of amino acids 1-7 of SEQ ID NO:1. This includes methods for identifying antibody fragments that can mimic the Fab fragments of 12A11 and 3D6, as well as designing humanized antibodies that bind to specific peptides.
Another significant patent focuses on alpha-synuclein kinase. This invention provides agents and methods for treating diseases associated with Lewy body diseases (LBDs) in the brain. Preferred agents include inhibitors of PLK2 kinase, showcasing Basi's commitment to addressing critical health issues.
Career Highlights
Throughout his career, Guriqbal Basi has worked with notable companies such as Elan Pharmaceuticals, Inc. and Elan Pharma International Limited. His experience in these organizations has contributed to his expertise in the field of biotechnology and pharmaceuticals.
Collaborations
Basi has collaborated with esteemed colleagues, including John P. Anderson and Sukanto Sinha. These partnerships have likely enhanced his research and development efforts, leading to innovative breakthroughs in antibody technology.
Conclusion
Guriqbal Basi stands out as a leading inventor in the realm of antibody research, with a strong portfolio of patents that address significant medical challenges. His work continues to influence the field and pave the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile